| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Buckhalter Matthew | Chief Financial Officer | C/O AVEANNA HEALTHCARE HOLDINGS INC., 400 INTERSTATE NORTH PARKWAY SE, ATLANTA | /s/ Jonathan Beckler, Attorney-in-Fact | 17 Feb 2026 | 0001983673 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVAH | Common Stock, par value $0.01 per share | Award | $0 | +15,213 | +3.5% | $0.000000 | 452,193 | 14 Feb 2026 | Direct | F1 |
| transaction | AVAH | Common Stock, par value $0.01 per share | Award | $0 | +46,875 | +10% | $0.000000 | 499,068 | 14 Feb 2026 | Direct | F2 |
| transaction | AVAH | Common Stock, par value $0.01 per share | Award | $0 | +66,205 | +13% | $0.000000 | 565,273 | 14 Feb 2026 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards. |
| F2 | Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards. |
| F3 | Grant of stock-settled restricted stock unit, subject to three-year cliff vesting. |